… This randomized phase III trial was designed to compare docetaxel and paclitaxel at … Results
from another phase III trial confirmed that docetaxel 100 mg/m 2 is associated with a higher …

… ), and encouraging phase II data testing estramustine and docetaxel with bevacizumab
suggested … A phase III study testing the effect of adding bevacizumab to standard docetaxel and …

… Studies in the ENTHUSE program were initiated to further assess the encouraging … earlier
randomized phase II study. In the current study, the addition of zibotentan 10 mg/d to docetaxel …

… Study Design TAXOMET is a randomized, double-blind, phase II study. Patients were
enrolled in 10 French centers from January 2013 to May 2018, and randomly assigned at a 1:1 …

… Docetaxel is one of the most active chemotherapies in breast cancer. Phase II studies of
second-line single-agent docetaxel … Phase III trials showed higher response rates with second-…

… patients receiving docetaxel in the current study … docetaxel on the phase III studies reported
by Shepherd et al 5 and Fossella et al. The RR to docetaxel at 75 mg/m 2 on all three studies …

… In these four phase II studies, in which docetaxel 100 mg/m 2 (D100) every 3 weeks was …
, a randomized phase III study was conducted that compared two doses of docetaxel versus a …

… studies support the addition of carboplatin to docetaxel, we performed a phase II trial
investigating the combination of docetaxel … versus docetaxel re-treatment in docetaxel pre-treated …

… toxicity of lower doses of docetaxel administered weekly [5, 6]. … randomized phase III study
in advanced NSCLC patients, comparing docetaxel 75 mg/m 2 every 3 weeks with docetaxel …

… biochemical response to first-line docetaxel and showed disease stabilization (… phase II
study we assessed activity and safety of docetaxel given as second-line therapy in docetaxel …